Do We Get Samples of the Report?

Yes, you will receive a sample copy of the market research report from the sales team when you put a query to us. The sample report is free and offers a brief view of the report and information on data available before you purchase the full-fledged report. Also, we will provide a demo sample for any oncoming study.

How to Buy a Market Report?

Select the report you wish to purchase and proceed to buy it by making an online payment. We use a secured gateway for payment transfers and do not share your financial information with any unconcerned third party.

In Which Format Will I Get the Report?

The report will be delivered in spreadsheet and PDF format. In some cases, PPT formats could be available as well.

In How Much Time I will Get the Report After Purchase?

After confirmation of the payment, you will receive the electronic format of the report at your registered email address in (mention the timeline for the delivery). If you buy a report over a holiday or weekend, we will process the request the next working day.

How Can I Get the Report Customized?

Market studies and reports already contain important data and are ready for distribution to the purchaser. However, if there is any particular query, addition, or customization you require, then contact us on our email id or phone. We will look to accommodate your request and see what can be done at the earliest. The research team will design the report accordingly and discuss the solutions beforehand with you.

How Much Will It Cost to Get a Report Customized?

The price of the customized report will be conveyed to you by our team after we agree on the deliverable. A delivery timeline will be set so that you get the report within the expected date. Any requests for customizations after selling the report will be handled by a separate department and the prices for the same mentioned upfront.

Can I Buy Only a Particular Segment of the Study?

While usually such a request is not accommodated as any market research report is wholesome and the cost of the report is for overall contents, in special cases, we may be able to sell select segments of the report based on your requirements.

Is There Any Available Discount?

Our team will love to support academicians, start-ups, students, and others with consulting and research. Thus, our pricing plan is based on keeping these interests in mind and is already affordable. However, we may have discounts available for particular customer types and reports. So, contact us for more information.

Which Services Are Complimentary Before Purchasing the Report?

We have consumer-centric reports and offer several facilities before selling. You will get a free review and sample report, talk to our customer care team for any additions to be done and meet special requirements, and interact with our analysts for deeper understanding.

Will I Receive a Bill or Invoice for the Report Purchased?

Yes, you will get an invoice for the purchase you made. The invoice will be sent to you electronically on your registered email id.

What If I am Unable to Find the Report in the Catalog?

We have a vast database of market reports and studies and there are a few which may not have been uploaded yet. If you are unable to find the one you want, then get in touch with our sales team by phone or email and we will connect with you for assistance.

How Often Are the Existing Studies Updated?

Not every study is the same. Thus, the update for reports will depend on the ongoing research and changes if any to be incorporated in the document or not.

What If the Report Does Not Contain the Information I Want?

The market research reports are constructed keeping in mind the industry trends, nature of the study, and required inputs. But if you want something more than what is stated in the report, we can help you out with further research if possible. Contact us right away, and we will do the needful to aid you.

Is the Payment Refundable?

Once the payment is done, it is non-refundable because as per the standard policy, the utility of the reports is based on knowledge sharing, and thus, a refund is not possible to make after we have issued you obtain the study. To avoid the hassle, we have a detailed view of the report and its ideas through a sample report.

What If the Payment Fails?

If the payment fails then be assured that you shall receive the money back to the source payment mode from the payment gateway. Aarkstore is not responsible for any loss of payment in the process.

Can I Avail the Report of a Particular Country/Region?

Yes, we can provide a report or segment related to a particular region or geography if we have that feature available for the document.

Do You Offer Support After Purchase?

Yes, we are here to solve any queries you may have for the report from our analyst till a given timeframe. To understand more about this, get in touch with us.

Alkermes Plc (ALKS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

DESCRIPTION

TABLE OF CONTENTS

RELATED REPORTS

SAMPLE REQUEST

REVIEWS

DESCRIPTION

Summary

Alkermes Plc (Alkermes) is a biopharmaceutical company that focuses on the research, development and commercialization of drugs for the treatment of central nervous system (CNS) diseases. The companys proprietary products include Aristada, an extended-release intramuscular injectable suspension for the treatment of schizophrenia; and Vivitrol, the only once-monthly, non-addictive, injectable medication for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence. It also grants license under its proprietary technologies to enable third parties to develop, commercialize and manufacture products. Alkermes sells its products primarily to wholesalers, specialty distributors and specialty pharmacies. The company also has a clinical pipeline of products that address CNS disorders such as multiple sclerosis, schizophrenia, depression and addiction. Alkermes is headquartered in Dublin, Ireland.

Alkermes Plc (ALKS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

TABLE OF CONTENTS

2
List of Tables 4
List of Figures 5
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Alkermes Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Alkermes Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Alkermes Plc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Civitas Therapeutics Raises USD55 Million in Series C Financing 11
Partnerships 13
Reset Therapeutics Enters into Co-Development Agreement with Alkermes 13
Licensing Agreements 14
Alkermes Enters into Licensing Agreement with Domain Therapeutics 14
Asset Transactions 14
Recro Pharma Acquires Certain Assets from Alkermes 14
Alkermes Plc - Key Competitors 17
Key Employees 18
Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Apr 27, 2017: Alkermes Reports First Quarter 2017 Financial Results 21
Feb 15, 2017: Alkermes Reports Financial Results for the Year Ended Dec. 31, 2016 and Provides Financial Expectations for 2017 22
Nov 02, 2016: Alkermes Reports Third Quarter 2016 Financial Results 24
Jul 28, 2016: Alkermes Reports Second Quarter 2016 Financial Results 25
Apr 28, 2016: Alkermes Reports First Quarter 2016 Financial Results 27
Feb 25, 2016: Alkermes Reports Financial Results for the Year Ended Dec. 31, 2015 and Provides Financial Expectations for 2016 28
Corporate Communications 30
May 30, 2017: Alkermes Appoints Craig Hopkinson, M.D., as Chief Medical Officer, and Senior Vice President, Clinical Development and Medical Affairs 30
May 26, 2016: Alkermes Appoints Nancy Snyderman, M.D., to Board of Directors 31
Government and Public Interest 32
Nov 03, 2016: ALKERMES Inspiration Grants Awarded to Support People Affected by Mental Health and Substance Use Disorders 32
Sep 12, 2016: Alkermes Launches Competitive Grants Program to Support People Affected by Mental Health and Substance Use Disorders 33
Clinical Trials 34
May 25, 2016: Alkermes Announces Initiation of Phase 1 Clinical Study of Immuno-Oncology Drug Candidate ALKS 4230 34
Jan 21, 2016: Alkermes Announces Topline Results of FORWARD-3 and FORWARD-4, Two Phase 3 Studies of ALKS 5461 in Major Depressive Disorder 35
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List Of Tables

Alkermes Plc, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Alkermes Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Alkermes Plc, Deals By Therapy Area, 2011 to YTD 2017 9
Alkermes Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Civitas Therapeutics Raises USD55 Million in Series C Financing 11
Reset Therapeutics Enters into Co-Development Agreement with Alkermes 13
Alkermes Enters into Licensing Agreement with Domain Therapeutics 14
Recro Pharma Acquires Certain Assets from Alkermes 14
Alkermes Plc, Key Competitors 17
Alkermes Plc, Key Employees 18
Alkermes Plc, Other Locations 20
Alkermes Plc, Subsidiaries 20

List Of Figures

Alkermes Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Alkermes Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

RELATED REPORTS

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

REVIEWS

There is no Reviews available

Search and Get the Latest Market Research Reports

Alkermes Plc (ALKS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review

Alkermes plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review

Alkermes plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

FAQs